Showing results (301-310 of 340) with videos related to

Sort By:
Pageof 34
Leukemia & Lymphoma|March 1, 1997
Mitotic activity and nuclear DNA damage of large cells in Hodgkin's disease: comparison with the expression of p53 and bcl-2 proteins and the presence of Epstein-Barr virusL Leoncini, D Spina, P Close, et al.
European Journal of Immunology|September 29, 2000
Defective recruitment and activation of ZAP-70 in common variable immunodeficiency patients with T cell defectsM Boncristiano, M B Majolini, M M D'Elios, et al.
The New England Journal of Medicine|November 24, 1983
Diagnosis of human lymphoma with monoclonal antileukocyte antibodiesR A Warnke, K C Gatter, B Falini, et al.
The American Journal of Surgical Pathology|May 1, 1994
Nodular lymphocyte predominance Hodgkin's disease. A distinct clinicopathological entityD Y Mason, P M Banks, J Chan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2009
Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcomeP L Zinzani, F Venturini, V Stefoni, et al.
International Journal of Cancer|November 15, 1996
Stage-related differences of mitotic and apoptotic indices, and bcl-2 protein expression in diffusely growing non-Hodgkin's lymphomasD Spina, L Leoncini, T Megha, et al.
The Journal of Pathology|June 1, 1997
Cellular kinetic and phenotypic heterogeneity in and among Burkitt's and Burkitt-like lymphomasD Spina, L Leoncini, T Megha, et al.
Haematologica|February 27, 2001
Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapyP L Zinzani, M Martelli, M Bendandi, et al.
Leukemia & Lymphoma|November 8, 2001
MACOP-B regimen followed by involved-field radiation therapy in early-stage aggressive non-Hodgkin's lymphoma patients: 14-year update resultsP L Zinzani, V Stefoni, M Tani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 13, 2006
Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patientsP L Zinzani, M Tani, S Fanti, et al.
Pageof 34